AVEO
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read moreAVEO
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
2001
PrivateAcquired by LG Chem Ltd.
News
Feb 25, 2025
The Economic Times
AVEO: Opioid drugs row: Aveo Pharma claims to have due licences
Sep 05, 2024
Indian Pharma Post
AVEO: AVEO Oncology announces acceptance of late-breaking oral presentation of TiNivo-2 results at ESMO 2024
Jul 19, 2024
The Pharma Letter
AVEO: Fotivda combo fails in earlier treatment setting
Jul 19, 2024
Clinical Trials Arena
AVEO: AVEO Oncology kidney cancer combo fails at Phase III
Jun 14, 2024
Clinical Trials Arena
AVEO: LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Apr 15, 2024
Pharamceutical Technology
AVEO: AVEO Pharmaceuticals gets grant for decreasing blood urea nitrogen levels in hyperuricemia using anti-gdf15 antibody
Feb 06, 2024
MarketScreener
AVEO: AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
Feb 02, 2024
Korea Biomedical Review
AVEO: LG Chem's life science sales exceed 1 tril. for 1st time with robust revenue from US unit
Jan 17, 2024
TechGenYZ
AVEO: LG Chem Set to Unveil Anticancer Drugs, Begin Ficlatuzumab Phase 3 Clinical Trial
Jan 17, 2024
KED Global
AVEO: LG Chem to start Phase 3 for head, neck cancer drug in US
AVEO Competitors
1
2
3
4
5
6
7
8
9